Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.50
Bid: 16.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.25%)
Open: 16.50
High: 16.50
Low: 16.50
Prev. Close: 16.50
INSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

3 Nov 2022 07:00

RNS Number : 1431F
Insig AI Plc
03 November 2022
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

3 November 2022 

 

Insig AI plc

("Insig AI", the "Company" or the "Group")

Trading update

Trading update and revised guidance with profitability now expected from Q2 2023

 

Insig AI plc (AIM:INSG), the data science and machine learning company, today announces a trading update and revised guidance resulting in expected profitability being generated earlier than previously forecast by management.

 

In the Company's final results published on 9 September 2022, the Company stated that a number of contract wins were anticipated to close before the end of October. On 30 September, the Company announced that it had won a contract with a value of £200,000.

 

Two weeks after the publication of the Company's final results, the "mini-budget" took place. As widely reported, this resulted in a sharp rise in borrowing costs, an unprecedented sell-off in UK index-linked government bonds, significant uncertainty and liquidity concerns in the pensions industry. Given Insig AI's focus on the asset management industry, this resulted in a number of our prospects understandably prioritising dealing with the impact on their businesses of sudden market turmoil. As a result of this recent unexpected wave of uncertainty, a number of contracts within our pipeline did not close by 31 October, however, many of these remaining prospects remain active.

 

Over the last 12 months, the Company has invested heavily to build a repository of machine learning ESG company disclosures on more than 2,500 global businesses. Our database now includes constituents of the S&P 500, the STOXX 600 and the FTSE 100/250/350 together with hundreds of non-listed corporates. The Company is confident that this repository can be utilised to deliver a long term revenue stream. Having secured this capability, the Company is now able to flex more of its costs based on orders received. Accordingly, the Board has taken the decision to substantially reduce ongoing costs in relation to the building of the repository of disclosures and the integration of the data filings capabilities.

 

The Board recognises the nascent nature of the ESG space and whilst improved disclosures and an end to greenwashing will be both welcome and inevitable, timings remain uncertain. Having now achieved critical mass within the 'stocks universe' with our repository and the resultant reduction in headcount and other costs noted above, the Board is able to prioritise and accelerate the timeline to expected profitability of the Group. As announced in September 2022, our focus is firmly set on: fintech data science solutions, new fund launches with associated sharing of management fees and selling our ESG proprietary scoring and comparison capabilities to the corporate market.

 

In March 2022, the Company provided revenue targets, which included asset managers as direct buyers of the ESG scoring tool and of data filings. Given the specialised nature of these data filings and our preference to partner with asset managers on new fund launches and fintech data science to generate improved alpha, that to achieve those revenue targets, significant further investment and cost would be required. The Board is therefore reducing these targets and, in turn, any associated costs of investment are now expected to result in an improved return on equity as well as higher operating margins.

 

As previously announced, with the receipt of the R&D tax credit, together with the convertible loan note facilities provided, it was expected that there would be sufficient working capital through to Q2 2023. The Board now believes that no further working capital will be required to support the operations of the business in the short and medium term, as the business is expected to become cash flow positive from Q2 2023 as a result of the cost cutting actions taken. Moreover, the Board also notes as per the announcement on 4 May 2022, the terms of the initial convertible loan note provided by Richard Bernstein stated that the loan was repayable on or before 31 December 2022. Whilst no formal agreement has been made, the Board is in positive discussions with Mr Bernstein to extend this repayment date, however, should the loan become repayable on or before 31 December 2022, the Company would need to raise additional capital.

 

Colm McVeigh, Insig AI's Chief Executive commented: "With recent uncertainty in the asset management and funding markets having increased significantly, we must adapt and accelerate the timing of profitability. Whilst it would have been ideal to have continued to expand our coverage into more smaller companies, the return on this investment would extend beyond our appetite. We prefer to focus on becoming cash positive sooner, which we hope to achieve in Q2 2023."

 

 

For further information, please visit www.insg.ai or contact:  

Insig AI plc

Colm McVeigh (CEO)

  Via SEC Newgate

 

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold / Danny Philips

+44 (0) 20 3829 5000

SEC Newgate (Financial PR)

Robin Tozer / Richard Bicknell

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGBDBLSGDGDD
12
Date   Source Headline
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSFunding facility, share allotment & PDMR dealing
2nd Apr 20247:00 amRNSTrading update & equity funding facility proposal
28th Dec 20237:00 amRNSInclusion within UN Environment Programme Tool
22nd Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSInterim results
28th Nov 20237:00 amRNSAppointment of investor relations adviser and TVR
27th Nov 20237:00 amRNSCorporate development adviser and TVR
15th Nov 20237:00 amRNSDisposal, Loan Conversion, New Project Win & TVR
30th Oct 20237:00 amRNSNew Product Launch
28th Sep 20237:00 amRNSAppointment of Strategic Adviser and TVR
15th Sep 20233:56 pmRNSResult of AGM
15th Sep 20237:00 amRNSAGM Statement
30th Aug 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20237:00 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSFinal Results, Posting of Report and Notice of AGM
1st Aug 20234:42 pmRNSChange of Registered Office
31st Jul 20235:30 pmRNSTotal Voting Rights
4th Jul 20237:00 amRNSRevision of Convertible Loan Facility Agreement
19th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Apr 20237:00 amRNSDeath of Director
24th Apr 20237:02 amRNSEquity subscription
24th Apr 20237:01 amRNSInsig AI Data & Technology Collaboration with FCA
24th Apr 20237:00 amRNSTrading and operations update
9th Mar 20237:00 amRNSInsig AI showcase Generative AI Product Capability
6th Feb 20237:00 amRNSGenerative AI Product Capability
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSConvertible Loan Facility Drawdown
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector Dealing
22nd Dec 20227:00 amRNSRevision of Convertible Loan Facility Agreements
21st Dec 20227:00 amRNSDirectors gift shares to Company treasury & TVR
19th Dec 20227:00 amRNSInterim Results
8th Nov 20227:00 amRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNSNew Contract Win
3rd Nov 20227:00 amRNSTrading update
26th Oct 20227:00 amRNSConvertible Loan Facility drawdown
17th Oct 20227:00 amRNSPartnership agreement with BRAIN
12th Oct 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
30th Sep 202212:13 pmRNSResult of Annual General Meeting & General Meeting
30th Sep 20227:00 amRNSContract win
26th Sep 20227:00 amRNSConvertible Loan Facility drawdown
20th Sep 20227:00 amRNSChange of Registered Office
12th Sep 20227:00 amRNSConvertible Loan Facility Agreement
9th Sep 20227:00 amRNSFinal Results, Posting of Report and Notice of GM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.